Ludwig Fund gives $120 million for cancer research
14th Nov 2006, 06:44 GMT
A foundation created by American billionaire, Daniel K. Ludwig, will this year give six leading US institutions $20 million cash each, plus stock in a New York real estate holding company, to create Ludwig Centers. The $120 million plus gift, with further distributions from the Ludwig Fund over the next six years, should ensure that each Ludwig Center receives annual research funds of approximately $2 million in perpetuity.
Ludwig Fund gives $120 million for cancer research related news:
- Ludwig Fund donates $20 million to University of Chicago for cancer research — EurekAlert! - Chemistry, Physics and Materials Sciences
- MIT receives Ludwig Fund cancer grant — United Press International - NewsTrack
- Ludwig Fund Gives $120 Million for Cancer Research Believed to Be Largest Single Gift by a Foundation for Cancer Research in the United States — mysan.de - Lifestyle News
- Ludwig Fund Gives $120 Million for Cancer Research — PR Newswire: All Releases
- MIT, Dana-Farber win major cancer grants — bizjournals.com Health Care:Pharmaceuticals headlines
- Hopkins to receive $20M for cancer research — Latest news from Baltimore Business Journal
- $120m gift for cancer research — Boston.com / News
- U Of C Gets $20 Million For Cancer Research — Chicago news, weather, sports, traffic and video from cbs2chicago.com: Health
- $120m gift for cancer research. — Environmental Health News
- Stanford Gets $20M Cancer-Stem Cell Site — RedOrbit News - Health
Latest news from EurekAlert! - Medicine and Health:
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
- UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
- Why do insects like to eat some plants more than others?
- Opposites do not attract
- Wild gorillas carriers of an SIV virus close to the AIDS virus
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
- Pourquié lab identifies genes involved in formation of vertebral precursors
- Artificial cornea offers better results for infants, some blind patients
- Healthier kids just the click of a remote away